| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Knight Therapeutics Inc | 20% | +17% | $3,536,116 | +$792,854 | 1,911,414 | +29% | KNIGHT THERAPEUTICS INC. | 11 Jun 2025 |
As of 31 Dec 2025, 12 institutional investors reported holding 1,297,093 shares of Synergy CHC Corp. - Common Stock, par value $0.00001 per share (SNYR). This represents 14% of the company’s total 9,605,095 outstanding shares.
The largest institutional shareholders of Synergy CHC Corp. - Common Stock, par value $0.00001 per share (SNYR) together control 14% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| GRATIA CAPITAL, LLC | 5.8% | 555,000 | 0% | 0.92% | $1,032,300 |
| HEARTLAND ADVISORS INC | 5.7% | 550,000 | 0% | 0.06% | $1,023,000 |
| VANGUARD GROUP INC | 0.99% | 95,107 | +44% | 0% | $176,899 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.38% | 36,038 | +30% | 0% | $67,029 |
| DRW Securities, LLC | 0.2% | 19,487 | 0% | $36,245 | |
| CITADEL ADVISORS LLC | 0.14% | 13,809 | 0% | $25,685 | |
| Warberg Asset Management LLC | 0.14% | 13,675 | -59% | 0.01% | $25,436 |
| JANE STREET GROUP, LLC | 0.11% | 10,464 | 0% | $19,463 | |
| BANK OF AMERICA CORP /DE/ | 0.02% | 1,544 | +4311% | 0% | $2,872 |
| UBS Group AG | 0.01% | 1,198 | +1161% | 0% | $2,228 |
| Tower Research Capital LLC (TRC) | 0.01% | 722 | 0% | $1,343 | |
| Clearstead Advisors, LLC | 0% | 49 | +96% | 0% | $92 |
| CITIGROUP INC | 0% | 0 | -100% | $0 | |
| SANDERS MORRIS HARRIS LLC | 0% | 0 | -100% | $0 | |
| Virtu Financial LLC | 0% | 0 | -100% | $0 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 1,297,093 | $2,412,592 | -$836,135 | $1.86 | 12 |
| 2025 Q3 | 1,640,098 | $4,001,535 | +$2,950,002 | $2.44 | 11 |
| 2025 Q2 | 427,288 | $1,217,771 | -$1,153,510 | $2.85 | 6 |
| 2025 Q1 | 905,310 | $2,128,805 | -$37,888 | $2.35 | 8 |
| 2024 Q4 | 911,017 | $4,046,331 | +$4,046,331 | $4.40 | 9 |